Metraipolis › archive › dc_2dc3ec843f09

Efficacy and safety of disitamab vedotin in treatment of advanced gastric cancer based on real-world — Europe PMC PMID:42245721

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42245721
DOI
10.3389/fonc.2026.1807824
License (as archived)
solo-consultazione
Archived
2026-11-01T13:26:55.634Z
SHA-256 of the archived text
74c225cdff63c1be6267daa0a0799faef73b6b0ab5e39adc7372f605335b5df7
Stable URL of this page
https://metraipolis.com/documento/dc_2dc3ec843f09

How to cite

Efficacy and safety of disitamab vedotin in treatment of advanced gastric cancer based on real-world — Europe PMC PMID:42245721 — Europe PMC (en), https://europepmc.org/article/MED/42245721 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2dc3ec843f09 (Metraipolis archive dc_2dc3ec843f09, sha256 74c225cdff63c1be6267daa0a0799faef73b6b0ab5e39adc7372f605335b5df7)
BibTeX
@misc{dc2dc3ec843f09,
  title = {Efficacy and safety of disitamab vedotin in treatment of advanced gastric cancer based on real-world — Europe PMC PMID:42245721},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42245721},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2dc3ec843f09; sha256 74c225cdff63c1be6267daa0a0799faef73b6b0ab5e39adc7372f605335b5df7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42245721. Agents can read the archived copy with the MCP tool read_document.